Movement Alert|UiPath Falls 5.27% in Pre-Market Trading, Q1 EPS Misses Expectations Despite Revenue Beat

Market Focus
May 29

On May 29, UiPath fell 5.27% in pre-market trading, trading at $10.96/share, with trading volume of $13.3582 million. The sell-off was triggered by the company's first-quarter earnings miss on the bottom line.

UiPath reported adjusted earnings per share of $0.15, missing the analyst consensus estimate of $0.16 by 6.25%. However, revenue came in at $418.382 million, surpassing the expected $397.812 million. Subscription and license revenue combined accounted for 97.10% of total revenue, underscoring the continuity of the company's core business model. For the second fiscal quarter, UiPath guided revenue of $395 million to $400 million, with full-year revenue guidance of $1.776 billion to $1.781 billion, both slightly above market expectations.

Separately, Bank of America raised its price target on UiPath from $12 to $13. The stock carries an average analyst rating of hold with a mean price target of $13.53, according to FactSet polling data. UiPath provides an end-to-end automation platform offering robotic process automation solutions designed to empower enterprises through automation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10